本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

La Jolla Pharmaceutical Company

6.22
0.0000
成交量:- -
成交额:166.46万
市值:1.55亿
市盈率:48.19
高:6.22
开:6.22
低:6.22
收:6.22
数据加载中...
2021/12/06

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/02

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/02

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/12/01

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/19

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/17

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/11/04

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/11/04

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/11/04

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/11/04

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/11/04

员工持股计划

S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2021/08/05

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/27

重要事件披露

8-K - Current report
2021/05/27

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/07

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/30

[修订]年度报告

10-K/A [Amend] - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/03/08

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/12

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/29

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals